Equity Profile

CC

The Chemours Company

MaterialsDiversified Chemicals$3.1B

May5Tue

Post-Earnings Recap

ReportedQ1-2026After Close4:58 PM EDT

The Chemours Company Beats on EPS, Stock Up 2.65%

Metric	Actual	Expected	Surprise
EPS	$0.05	$-0.04	+194.34%
Revenue	N/A	$1.4B	N/A

management commentary, guidance changes, and full analysis available with Pro.

The Chemours Company Beats on EPS, Stock Up 2.65%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.05	$-0.04	+194.34%
Revenue	N/A	$1.4B	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

The Chemours Company's earnings report showed a significant positive surprise in EPS, which likely contributed to the stock's 2.65% increase. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may view the EPS beat as a sign of better-than-expected profitability, but the lack of revenue data could lead to cautious sentiment moving forward.

Company Snapshot

The Chemours Company (CC) is a global leader in the diversified chemicals sector, known for its innovative products in titanium technologies, fluoroproducts, and chemical solutions. As a key player in materials, Chemours' performance is closely tied to industrial demand and environmental regulations, making it an important company to watch in the current economic landscape.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial indicator of profitability and helps investors gauge the company's financial health.

$-0.04

Revenue

Revenue figures provide insight into the company's sales performance and overall market demand.

$1.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

In Q4 2025, Chemours reported an EPS of $0.05, significantly beating expectations of $0.00. However, the stock fell 3.50% the following day, indicating mixed market reactions despite the positive earnings surprise.

Management Promises & Guidance

Focus on cost management and operational efficiency.
Commitment to sustainable product development.
Plans to expand market presence in emerging economies.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Chemours' upcoming earnings, with expectations of a slight loss in EPS but stable revenue figures. The market is closely watching for any signs of recovery in demand and cost management strategies.

Bull Case

If Chemours can exceed EPS expectations and show strong revenue growth, it could signal a robust recovery in demand and operational efficiency, leading to positive market sentiment.

Bear Case

Conversely, if the company reports a larger loss than expected or provides weak guidance, it could raise concerns about ongoing challenges in the market and lead to a negative reaction from investors.

Key Metrics to Watch

Earnings Per Share (EPS)

$-0.04

EPS is a crucial indicator of profitability and helps investors gauge the company's financial health.

Revenue

$1.4B

Revenue figures provide insight into the company's sales performance and overall market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Chemours achieve a positive EPS this quarter, or will it fall deeper into the negative range?

A positive EPS would indicate strong operational performance, while a deeper loss could signal ongoing challenges in the market.

What are the revenue figures for the quarter, and how do they compare to the consensus estimate of $1.4B?

Revenue performance is critical for assessing demand and the company's market position, impacting investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Chemours' ability to manage costs effectively, which could lead to a better-than-expected EPS despite current challenges.

Supporting Evidence

The company has a history of beating EPS estimates, with a 75% success rate over the last eight quarters.

Recent operational improvements and cost management strategies may not be fully reflected in analyst expectations.

Key Risk

If Chemours reports an EPS above $0.00, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the company's ability to manage costs and meet market demand amidst economic uncertainties.

Bull Confirmed If

An EPS of $0.03 or better would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS of $-0.14 or worse would confirm the bear case, raising concerns about demand and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±11.20%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±10.8% while CC has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.3%

30d HV

50.3%

Calls (185K)P/C Ratio: 1.03Puts (191K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 5 of 11 (45%)

This setup has occurred 30 times across Materials in the last 2 years. 5 of 11 faded and 6 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.2%, with a raw directional average of -0.1% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a potential stock increase of around +2.22%, confirming a positive outlook.

In-Line / Cautious

An in-line result may lead to a muted response, as investors await further commentary on future guidance and market conditions.

Miss

If the company misses expectations, history suggests a potential decline of around -1.78%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management initiatives and their impact on profitability.
2Insights into demand trends for Chemours' key products.
3Management's outlook on market conditions and potential growth areas.
4Discussion of any regulatory impacts on production and sales.
5Details on strategic investments or partnerships that may enhance future performance.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial indicator of profitability and helps investors gauge the company's financial health.

$-0.04

Revenue

Revenue figures provide insight into the company's sales performance and overall market demand.

$1.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+329.95%

Avg Stock Reaction

+1.98%

Last Quarter Recap

Management Promises & Guidance

Focus on cost management and operational efficiency.
Commitment to sustainable product development.
Plans to expand market presence in emerging economies.

Expectations

Wall Street Expectations

Bull Case

If Chemours can exceed EPS expectations and show strong revenue growth, it could signal a robust recovery in demand and operational efficiency, leading to positive market sentiment.

Bear Case

Key Metrics to Watch

Earnings Per Share (EPS)

$-0.04

EPS is a crucial indicator of profitability and helps investors gauge the company's financial health.

Revenue

$1.4B

Revenue figures provide insight into the company's sales performance and overall market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Chemours achieve a positive EPS this quarter, or will it fall deeper into the negative range?

A positive EPS would indicate strong operational performance, while a deeper loss could signal ongoing challenges in the market.

What are the revenue figures for the quarter, and how do they compare to the consensus estimate of $1.4B?

Revenue performance is critical for assessing demand and the company's market position, impacting investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Chemours' ability to manage costs effectively, which could lead to a better-than-expected EPS despite current challenges.

Supporting Evidence

The company has a history of beating EPS estimates, with a 75% success rate over the last eight quarters.

Recent operational improvements and cost management strategies may not be fully reflected in analyst expectations.

Key Risk

If Chemours reports an EPS above $0.00, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on the company's ability to manage costs and meet market demand amidst economic uncertainties.

Bull Confirmed If

An EPS of $0.03 or better would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS of $-0.14 or worse would confirm the bear case, raising concerns about demand and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±11.20%

Historical Avg

±4.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±10.8% while CC has averaged ±4.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.3%

30d HV

50.3%

Calls (185K)P/C Ratio: 1.03Puts (191K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Materials

n=30

Fade rate: 5 of 11 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Chemours beats expectations, history suggests a potential stock increase of around +2.22%, confirming a positive outlook.

In-Line / Cautious

An in-line result may lead to a muted response, as investors await further commentary on future guidance and market conditions.

Miss

If the company misses expectations, history suggests a potential decline of around -1.78%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management initiatives and their impact on profitability.
2Insights into demand trends for Chemours' key products.
3Management's outlook on market conditions and potential growth areas.
4Discussion of any regulatory impacts on production and sales.
5Details on strategic investments or partnerships that may enhance future performance.